Showing 1 - 1 results of 1 for search 'Yvette Hoade', query time: 0.02s Refine Results
  1. 1
    Ruxolitinib, a potent JAK1/JAK2 inhibitor, induces temporary reductions in the allelic burden of concurrent CSF3R mutations in chronic neutrophilic leukemia

    Ruxolitinib, a potent JAK1/JAK2 inhibitor, induces temporary reductions in the allelic burden of concurrent CSF3R mutations in chronic neutrophilic leukemia by Arief S. Gunawan, Donal P. McLornan, Bridget Wilkins, Katherine Waghorn, Yvette Hoade, Nicholas C. P. Cross, Claire N. Harrison

    Published 2017-06-01
    Get full text
    Article

Search Tools: